通过调节STAT1-PD-L1轴,BATF驱动子宫癌的进展和免疫逃避
Jun Zhang1, Yang Zhang1, Jinwei Zhang1
1Department of Gynecology, The Affliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center, Nanjing Medical University, Wuxi People's Hospital, Wuxi, Jiangsu 214023, China.
Iranian journal of immunology : IJI
|March 6, 2026
概括
转录因子BATF通过激活STAT1和PD-L1.1,促进子宫癌的生长和免疫逃避. 针对BATF可能会改善癌症免疫治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 宫癌的进展涉及免疫逃避,特别是通过PD-L1抑制T细胞活性.
- 转录因子BATF在瘤免疫力中的作用是公认的,但在癌症中尚不完全理解.
研究的目的:
- 在宫癌进展中研究BATF-STAT1-PD-L1信号轴.
- 阐明BATF在调节瘤免疫和进展中的作用.
主要方法:
- 对宫癌组织和细胞系中BATF表达的分析.
- 在BATF淘汰后的功能性测试 (增殖,亡,自,迁移).
- 染色体免疫沉和西部斑点来评估STAT1规则.
- 用于PD-L1表达的流细胞计和瘤生长和免疫治疗反应的体内异种移植模型.
主要成果:
- 在宫癌中,BATF被上调,促进瘤生长,转移和免疫逃避.
- 降低BATF抑制了扩散,增强了亡和自,减少了迁移.
- BATF转录激活了STAT1,导致PD-L1诱导. 抑制BATF增加了CD8+T细胞的透,并增强了PD-L1阻断的有效性.
结论:
- 通过STAT1和PD-L1调制,BATF驱动子宫癌的进展.
- 针对BATF提供了一种潜在的策略,以提高抗瘤免疫力和免疫疗法的有效性.
相关概念视频
The Intrinsic Apoptotic Pathway
9.0K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.0K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Interactions Between Signaling Pathways
7.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.6K
B Cell Activation and Differentiation
17.6K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.6K


